GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

Nurse practitioner Shawnda Dorantes says weight-loss drugs are “helping people reclaim their health and confidence like never ...